Dual antiplatelet therapy after percutaneous coronary intervention and drug-eluting stents: a systematic review and network meta-analysis
Background: The optimal duration of dual antiplatelet therapy (DAPT) after percutaneous
coronary intervention with drug-eluting stents remains uncertain. We compared short-term (< …
coronary intervention with drug-eluting stents remains uncertain. We compared short-term (< …
Dual Antiplatelet Therapy After Percutaneous Coronary Intervention and Drug-Eluting Stents: A Systematic Review and Network Meta-Analysis
SU Khan, M Singh, S Valavoor, MU Khan… - …, 2020 - pubmed.ncbi.nlm.nih.gov
Background The optimal duration of dual antiplatelet therapy (DAPT) after percutaneous
coronary intervention with drug-eluting stents remains uncertain. We compared short-term (< …
coronary intervention with drug-eluting stents remains uncertain. We compared short-term (< …
[PDF][PDF] Dual Antiplatelet Therapy After Percutaneous Coronary Intervention and Drug-Eluting Stents
SU Khan, M Singh, S Valavoor, MU Khan, AN Lone… - Circulation, 2020 - isoic.org
BACKGROUND: The optimal duration of dual antiplatelet therapy (DAPT) after percutaneous
coronary intervention with drug-eluting stents remains uncertain. We compared short-term (< …
coronary intervention with drug-eluting stents remains uncertain. We compared short-term (< …
Dual Antiplatelet Therapy After Percutaneous Coronary Intervention and Drug-Eluting Stents: A Systematic Review and Network Meta-Analysis
SU Khan, M Singh, S Valavoor, MU Khan, AN Lone… - …, 2020 - ingentaconnect.com
Background: The optimal duration of dual antiplatelet therapy (DAPT) after percutaneous
coronary intervention with drug-eluting stents remains uncertain. We compared short-term …
coronary intervention with drug-eluting stents remains uncertain. We compared short-term …
[HTML][HTML] Dual Antiplatelet Therapy After Percutaneous Coronary Intervention and Drug-Eluting Stents: A Systematic Review and Network Meta-Analysis
SU Khan, M Singh, S Valavoor, MU Khan, AN Lone… - Circulation, 2020 - ncbi.nlm.nih.gov
BACKGROUND: The optimal duration of dual antiplatelet therapy (DAPT) after percutaneous
coronary intervention with drug-eluting stents remains uncertain. We compared short-term (< …
coronary intervention with drug-eluting stents remains uncertain. We compared short-term (< …
Dual Antiplatelet Therapy After Percutaneous Coronary Intervention and Drug-Eluting Stents: A Systematic Review and Network Meta-Analysis
SU Khan, M Singh, S Valavoor, MU Khan… - …, 2020 - pure.johnshopkins.edu
Background: The optimal duration of dual antiplatelet therapy (DAPT) after percutaneous
coronary intervention with drug-eluting stents remains uncertain. We compared short-term (< …
coronary intervention with drug-eluting stents remains uncertain. We compared short-term (< …
Dual Antiplatelet Therapy After Percutaneous Coronary Intervention and Drug-Eluting Stents
SU Khan, M Singh, S Valavoor, MU Khan, AN Lone… - Circulation, 2020 - cir.nii.ac.jp
抄録< jats: sec>< jats: title> Background:</jats: title>< jats: p> The optimal duration of dual
antiplatelet therapy (DAPT) after percutaneous coronary intervention with drug-eluting stents …
antiplatelet therapy (DAPT) after percutaneous coronary intervention with drug-eluting stents …
Dual Antiplatelet Therapy After Percutaneous Coronary Intervention and Drug-Eluting Stents: A Systematic Review and Network Meta-Analysis.
SU Khan, M Singh, S Valavoor, MU Khan, AN Lone… - Circulation, 2020 - europepmc.org
Background The optimal duration of dual antiplatelet therapy (DAPT) after percutaneous
coronary intervention with drug-eluting stents remains uncertain. We compared short-term (< …
coronary intervention with drug-eluting stents remains uncertain. We compared short-term (< …
Dual Antiplatelet Therapy After Percutaneous Coronary Intervention and Drug-Eluting Stents: A Systematic Review and Network Meta-Analysis
SU Khan, M Singh, S Valavoor… - …, 2020 - utsouthwestern.elsevierpure.com
Background: The optimal duration of dual antiplatelet therapy (DAPT) after percutaneous
coronary intervention with drug-eluting stents remains uncertain. We compared short-term (< …
coronary intervention with drug-eluting stents remains uncertain. We compared short-term (< …
Dual Antiplatelet Therapy After Percutaneous Coronary Intervention and Drug-Eluting Stents
SU Khan, M Singh, S Valavoor, MU Khan, AN Lone… - Circulation, 2020 - Am Heart Assoc
BACKGROUND: The optimal duration of dual antiplatelet therapy (DAPT) after percutaneous
coronary intervention with drug-eluting stents remains uncertain. We compared short-term (< …
coronary intervention with drug-eluting stents remains uncertain. We compared short-term (< …